DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.
The American Cancer Society has a long history of awarding grants to DCI researchers as they work to better understand the complexities of cancer and develop new treatments.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Dorothy Sipkins, MD, PhD, and P. Kelly Marcom, MD, are co-PIs on a Phase 1 clinical trial of a new drug for breast cancer patients whose disease has spread to the bone.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Dorothy Sipkins, MD, PhD, is developing a clinical trial of a new therapy that may force hidden breast cancer cells out of the bone marrow and back into the bloodstream.
Kids & Dogs’ Shared Cancers: Industry Leaders Stress Collaboration to Speed Drug Development at Canines-N-Kids’ Paws for a Cure Symposium (Associated ...
When Duke Cancer Institute researcher Christopher Pirozzi, PhD, was an intern doing stem cell research in Australia, he spotted a child’s mobile of a ...
Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be ...
A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system. ALL in the central nervous system is very diffic...
Five Duke School of Medicine faculty members have been elected to the American Society for Clinical Investigation (ASCI) Class of 2017. Of the five se...